University of Saskatchewan

September 23, 2014   

Distinguished Researchers - 1994

Lorne Babiuk
   Spring, 1994
Lorne Babiuk
Professor of Veterinary Microbiology
Western College of Veterinary Medicine
and Director of V.I.D.O.
(Veterinary Infectious Disease Organization)

Dr. Babiuk joined the University of Saskatchewan as an Assistant Professor in 1973 and holds a B.S.A. in Soil Science and a M.Sc. in Soil Microbiology from this University and a Ph.D. in Microbiology (virology) from the University of British Columbia. At the University of Saskatchewan, Professor Babiuk has earned world-wide recognition for his research in veterinary microbiology and role in the development of the Veterinary Infectious Disease Organization (V.I.D.O.).

Dr. Babiuk’s research, published in 300 scientific publications, contributes significantly to our knowledge and understanding of infectious diseases of animals. Specifically, his achievements are in immunomodulation (the use of natural and synthetic compounds to enhance animals’ resistance to infection), viral pathogenesis (viral disease processes) and vaccine development.

Under Dr. Babiuk’s direction, the VIDO scientific team develops vaccines from inception to market, including the first genetically-engineered vaccine for a bacterial infection for use in animals. These research achievements, which focus in part on "shipping fever" among cattle, have a positive impact on the daily economic life of Canada’s agriculturists. His expertise and reputation as a scientist permits Dr. Babiuk to forge productive links between the University, livestock producers, government agencies and industry that enable VIDO to be a world leader of infectious disease research.

Dr. Babiuk has supervised 17 Ph.D. and M.Sc. students and 18 Post Doctoral Fellows and is supervising 11 graduate students and 5 post Doctoral Fellows. Professor Babiuk has maintained teaching responsibilities at the undergraduate level and received the Norden Award, WCVM major teaching award, and the WCVM Preclinical Professor of the Year Award.

Professor Babiuk communicates effectively his research to the producer, to international scientists, and to industry representatives. In recognition of his research expertise, Dr. Babiuk has served on national and international research boards, including MRC, NSERC, NRC, and biotechnology and agriculture committees for the Canadian and US governments.

His research contributions have been recognized locally, nationally and internationally with awards including Rotarian Wheels in Science and Technology, a Centennial Lectureship at the University of Toronto, the Bill Snowden Memorial Award in Australia, the Distinguished Lectureship at Colorado State University, and the Xerox Canada Forum Award for fostering co-operation between universities and industry. The University of Saskatchewan recognized his scholarship with an earned D.Sc. degree in 1987.



Kamal K. Midha
   Fall, 1994
Kamal K. Midha
College of Pharmacy

Dr. Midha joined the College of Pharmacy at the University of Saskatchewan in 1979, following a distinguished and productive career in government. He holds a D.Pharm. and M.Pharm. from the University of Saugar, and a Ph.D. from the University of Alberta.

Dr. Midha’s research on psychotic drugs began 25 years ago with an effort to provide reliable pharmacokinetic and pharmacodynamic data. Perhaps the most significant breakthrough in his research was the development of a new approach to clinical pharmacokinetic-pharmacodynamic relationships in schizophrenic patients. The technique minimizes the extent to which the therapeutic benefits of the drugs are compromised by disabling side effects. This research significantly improved the quality of life for schizophrenic patients, enabling many to lead more normal and productive lives and reducing the incidences of exacerbation and hospitalization.

Dr. Midha has authored or co-authored nearly 250 scientific papers in refereed journals, chapters in books, and review articles, and presented many invited papers in the area of drug analysis, drug metabolism, pharmacokinetics and pharmacogenetics, bioavailability and bioequivalence.

Scientific publications are only one measure of his outstanding contributions to clinical research and practice in the treatment of schizophrenia. He is also on the forefront of research on the use of methylphenidate (Ritalin) in children and young adults with Attention Deficit Hyperactivity Disorder and has made significant studies on the pharmacokinetics and pharmacodynamics of this drug. Dr. Midha contributes to the intellectual life of this university as a supervisor or co-supervisor of graduate students, post-doctoral fellows, and highly skilled research personnel, and by promoting scholarly exchanges with outstanding international scientists.

At this University, Dr. Midha established the Drug Metabolism, Drug Disposition Research Group, in the College of Pharmacy and Nutrition and the College of Medicine, and a satellite laboratory at the University of California, Los Angeles. This group attracted nearly $6.2 million from the Medical Research Council and Industry. His accomplishments are recognized by professional associations through distinguished research awards such as the Heinz Lehmann Award (Canadian College of Neuropsychopharmacology), Research Achievement Award in Analysis and Pharmaceutical Quality (American Association of Pharmaceutical Scientists), the Kolthoff Gold Medal Award in Analytical Chemistry (American Pharmaceutical Association), and an earned D.Sc. from this University.